Law Firms Announce Investor Lawsuits

- The lawsuit against Kyndryl Holdings alleges the company misrepresented its cash management practices and the effectiveness of its internal financial controls for fiscal year 2025 and the first three quarters of fiscal year 2026. This follows a 55% drop in its stock price on February 9, 2026, after Kyndryl announced a delay in its financial statements, an SEC inquiry, and the immediate departure of its CFO and General Counsel. The class period for investors is from August 7, 2024, to February 9, 2026. - The securities fraud lawsuit against Beyond Meat claims the company misled investors by not disclosing that the book value of some assets was overstated, making a significant non-cash impairment charge probable. Beyond Meat later revealed a $77.4 million impairment charge, which led to multiple stock price drops, including a 23% fall on October 24, 2025. The class period for this lawsuit covers investors who purchased stock between February 27, 2025, and November 11, 2025. - The Pomerantz Law Firm's investigation into Beta Bionics was initiated after the company's stock price fell over 37% on January 9, 2026. The drop followed the company's disclosure of a 36% year-over-year increase in new patient starts for the fourth quarter, a significant slowdown from the 68% increase reported in the previous quarter. - The investigation into Navan concerns potential securities fraud following its IPO on October 30, 2025. On December 15, 2025, the company reported a GAAP operating loss of $79 million for the third quarter, a substantial increase from the $19 million loss in the same period of the prior year, and also announced the immediate departure of its Chief Financial Officer. This news caused the stock to fall 11.9%.